INTRODUCTION
============

Septic arthritis is an orthopedic disease that is difficult to characterize epidemiologically [@b1-cln_70p30],[@b2-cln_70p30]. In adults, the lower limbs are more often affected, with the knees being the site of highest incidence, followed by the hips [@b3-cln_70p30]-[@b5-cln_70p30]. In recent years, the prevalence of this infection has increased due to the greater number of invasive orthopedic procedures, the aging population and the increased use of immunosuppressant drugs [@b6-cln_70p30],[@b7-cln_70p30].

The most common microbial agent in septic arthritis is *Staphylococcus aureus*, with a prevalence of approximately 50% [@b8-cln_70p30],[@b9-cln_70p30]. This bacterium is the most commonly found in all age groups, with the exception of children younger than two years of age. Over the last few years, particularly since 2000, there has been an increasing incidence of oxacillin-resistant strains of this bacterium (MRSA) [@b8-cln_70p30]-[@b11-cln_70p30].

Infections by MRSA are increasing, particularly among the elderly, intravenous drug users and patients who have undergone orthopedic procedures. This increase has become a public health care issue in many parts of the world [@b6-cln_70p30],.

According to previously conducted studies, MRSA infections cause more suppurative complications, prolonged fevers and longer hospitalizations [@b15-cln_70p30],[@b16-cln_70p30].

This situation may be related to a failure to consider the causative agent in the initial empirical antibiotic therapy. Weston et al. showed that a delay in starting treatment, which can occur in cases in which the agent is not considered in the initial antibiotic therapy, led to a worse prognosis for the disease [@b17-cln_70p30].

The objective of this research was to establish the risk factors for joint infections due to MRSA, through a study of clinical and epidemiological data. The results of this research could lead to the consideration of this etiological agent in the first line of empirical antibiotic therapy for affected patients.

METHODS
=======

All of the cases of septic arthritis of the knee and hip diagnosed and treated in our institution from 2006 to 2012 were evaluated retrospectively. All of the records of patients with IDC-10 diagnoses of septic arthritis were located and the epidemiological, clinical and laboratory data were collected through a detailed chart review, with the information recorded on a standard form. Patients diagnosed with infections for less than a year following a surgical procedure on the affected limb were excluded because these cases were considered to be possible infections of the surgical site. Patients with infections associated with joint prostheses were also excluded.

Only patients with a culture identifying a microbial agent in the initial diagnostic puncture or from surgical drainage were included. All of the cultures were obtained in appropriate surgical environments using rigorous aseptic techniques and the materials were deposited in thioglycate tubes. All of the analyses and procedures were performed according to the standards established by the Clinical and Laboratory Standards Institute (CLSI) [@b18-cln_70p30]. Among the selected patients, those with a positive culture for *S. aureus* were divided into two groups: strains sensitive to oxacillin (MSSA) and strains resistant to this antibiotic (MRSA).

The following parameters were analyzed for all of the patients: sex; age; cause of infection; the provenance of the patient to categorize the infection as community- or health services-related, as described by the guidelines of the Centers for Disease Control and Prevention [@b19-cln_70p30]; leukocyte count, C-reactive protein (CRP) and erithrocytes sedimentation rate (ESR) values from the initial blood analysis; the presence of clinical signs, such as fever, pain, or swelling in the knee or hip; the number of surgical drainages performed; clinical comorbidities (high blood pressures and diabetes); prior orthopedic surgeries of the limb or joint affected; immunosuppression (HIV, inflammatory arthritis, cancer); the time from onset of symptoms to drainage; previous joint pain; systemic and articular complications; and hospitalization time. Gram staining and synovial fluid culture results were also analyzed.

Univariate statistical analysis was performed using the chi-square or Fisher\'s exact test, or likelihood ratio tests when the frequency of the event was very low.

The tests were conducted with a level of significance of 5%.

The study was conducted following approval from the science and research ethics committee of our institution.

RESULTS
=======

Between 2006 and 2012, 76 cases of septic knee and hip arthritis were drained and presented positive cultures. *S. aureus* was isolated in 35 (46.0%) of these patients, in the knee in 25 cases and in the hip in the remaining 10 cases.

Twenty-two of these patients presented with MSSA and 13 presented with MRSA. The average age of the patients with MRSA was 40.5+/-24.9 years old (ranging from 3 to 74 years) and the average age of those with MSSA was 39.2+/-20.9 years old (ranging from 7 to 76 years).

All of the studied data are summarized in [Table 1](#t1-cln_70p30){ref-type="table"}.

Following univariate statistical analysis, provenance of the patient from a health service-related environment was the only variable associated with the presence of oxacillin-resistant bacterial strains (*p* = 0.001). Both prior surgery of the limb or joint affected and the absence of a change in the leukocyte count suggested a higher frequency of MRSA isolation but without statistical significance ([Table 2](#t2-cln_70p30){ref-type="table"}).

DISCUSSION
==========

Septic arthritis is an infection that has a significant impact on our environment. Our case series presented an average of approximately 11 cases per year, with approximately 5 cases in which *S. aureus* was identified among the cultures. Eder et al., in a 17-year analysis from Israel, found only 110 confirmed cases, while in Switzerland, Clerc et al. encountered 83 cases in 10 years, considering only knees and hips [@b20-cln_70p30],[@b21-cln_70p30].

*S. aureus* is the most common agent identified in cases worldwide, with higher prevalence rates reported in Europe, Asia, the Middle East, Africa, the United States and South America [@b14-cln_70p30],. Some studies, such as those conducted by Frazee et al. in the United States and by Yamagishi in Japan [@b14-cln_70p30],[@b27-cln_70p30], have shown a higher proportion of MRSA relative to MSSA. In our case series, MSSA strains remained the majority.

In cases of MRSA, patients might not receive appropriate initial empirical antibiotic treatment because the resistance profile can only be identified from the results of cultures collected from the initial puncture or from surgical drainage. Thus, it is critical to attempt to identify risk factors for the presence of MRSA, with the aim of improving the efficacy of the initial antibiotic therapy. In their series, Yamagishi et al., Clerc et al., and Helito et al. found it necessary to broaden the antibiotic therapy spectrum after analyzing definitive cultures with an antibiogram [@b20-cln_70p30],[@b25-cln_70p30],[@b27-cln_70p30].

Among the variables analyzed in this study, the only one with a confirmed statistical correlation for the presence of MRSA was the provenance of the patient. Patients with a close relationship with health care services, according to the definition of the Centers for Disease Control and Prevention [@b19-cln_70p30], had a greater likelihood of presenting cultures positive for MRSA. The higher prevalence of infections in hospital services and in asymptomatic carriers of this bacterium has been described previously [@b14-cln_70p30],[@b21-cln_70p30].

Among the variables that suggested a relationship with MRSA, we believe that surgery performed previously on the limb or affected joint might have high significance. Causative agents of musculoskeletal infections are often present in an inactive state, manifesting themselves later. Courvoisier et al. described two cases of osteomyelitis of the tibia that manifested twenty years after a surgical procedure of the leg [@b28-cln_70p30]. These situations could warrant special attention and broadening of the spectrum of antibiotics used for the initial presentation.

Unlike the situation with limb surgeries, we did not find a plausible explanation for the absence of leukocytes in cases affected by MRSA. According to the studies of Arnold et al. and Martinez-Aguilar et al., MRSA infections evolve with more fevers and suppurative complications, conditions that are usually associated with an increased leukocyte count; however, this was not the finding in our case series [@b15-cln_70p30],[@b16-cln_70p30]. Further studies with more patients must be conducted to confirm this result.

None of the other variables studied reflected a difference between the MRSA and MSSA groups, not even the presence and number of comorbidities or immunosuppression; therefore, distinguishing this profile of sensitivity in the initial presentation remains difficult.

This study had some limitations, such as the retrospective data analysis and the relatively small number of patients. However, given the lack of literature data on this subject in our country, we believe that this analysis could be very relevant.

Provenance from a health services-related environment was associated with a higher incidence of septic arthritis related to MRSA, suggesting that this agent should be considered in the initial selection of an antibiotic treatment. Prior surgeries to the affected joint or limb and the absence of leukocytes might also be related to articular infections caused by this agent.
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###### 

Clinical and epidemiological summary of study results and statistical analysis.

                                                    MRSA group   MSSA group   *p*
  ------------------------------------------------- ------------ ------------ -----------
  **Sex**                                                                     0.708
      Male                                          8 (61.5%)    16 (72.7%)   
      Female                                        5 (38.5%)    6 (27.3%)    
  **Average age (years old)**                       40.5         39.2         0.871
  **Diagnostics**                                                             
      Leukocytosis                                  5 (38.5%)    15 (68.1%)   **0.086**
      Leukocyte count (average)                     10853        12915        0.325
      CRP increase (number of patients)             12 (92.3%)   22 (95.6%)   
      CRP value (average)                           150          166          0.749
      ESR increase (number of patients)             12 (92.3%)   22 (95.6%)   
      ESR value (average)                           69           58           0.394
      Fever                                         5 (38.5%)    9 (40.9%)    0.886
      Pain                                          10 (76.9%)   15 (68.1%)   0.709
      Joint effusion                                10 (76.9%)   17 (77.2%)   \>0.999
      Time to diagnosis (days)                      11.4         16.6         0.585
      Gram staining                                 7 (53.8%)    14 (63.6%)   0.568
  **Etiology**                                                                0.586
      Hematogenic                                   12 (92.3%)   20 (91.0%)   
      Direct inoculation                            0            1 (4.5%)     
      Contiguity                                    1 (7.7%)     1 (4.5%)     
  **Patient provenance**                                                      **0.001**
      Community                                     2 (15.3%)    16 (72.7%)   
      Health Services                               11 (84.7%)   6 (27.3%)    
  **Previous articular disease**                    5 (38.5%)    8 (36.3%)    \>0.999
  **Comorbidities**                                 10 (76.9%)   10 (45.4%)   0.282
  **Number of comorbidities (average)**             1.6          0.8          0.09
  **Immunosuppression**                             5 (38.5%)    5 (22.7%)    0.444
  **Previous joint surgery**                        4 (30.7%)    1 (4.5%)     **0.052**
  **Previous limb surgery**                         5 (38.5%)    2 (9.0%)     **0.075**
  **Treatment**                                                               
      Number of procedures per patients (average)   2.3          1.6          0.154
      Hospitalization days per patient (average)    32.8         21.5         0.109
      Systemic complications                        3 (23.0%)    2 (9.0%)     0.337
      Articular complications                       3 (23.0%)    4 (18.1%)    \>0.999

###### 

Statistical analysis.

  Variable                                  *p*
  ----------------------------------------- -----------
  Joint                                     0.259
  Sex                                       0.708
  Inoculation type                          0.586
  **Provenance**                            **0.001**
  Fever                                     0.886
  Pain                                      0.709
  Swelling                                  \>0.999
  Grams staining                            0.568
  Comorbidities                             0.282
  Number of comorbidities                   0.09
  Immunosuppression                         0.444
  Prior joint disease                       \>0.999
  Previous surgery of the affected joint    0.052
  Previous surgery of the affected limb     0.075
  Systemic complications                    0.337
  Articular complications                   \>0.999
  Leukocyte count                           0.325
  Leukocytosis                              0.086
  CRP value                                 0.749
  ESR value                                 0.394
  Number of drainages                       0.154
  Time from drainage to onset of symptoms   0.585
  Hospitalization time                      0.109
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